Ensuring inspection readiness is critical in clinical trials, and the updated ICH E6(R3) guidelines are reshaping the approach. In our latest webinar https://lnkd.in/g4qHdNHu, Allucent GXP expert, J Ernesto Vera-Sánchez, MD, PhD, MPH, dives into the key changes, including risk-proportionate strategies and the importance of data governance, patient safety, and regulatory compliance. Learn how to proactively manage risks, prepare your team for inspections, and stay compliant across all trial phases. Watch now for actionable insights to strengthen your inspection readiness and improve trial outcomes. #GCP #ICH #ClinicalTrials #Regulatory #InspectionReadiness #RiskManagement
SVP at Allucent
3dHighly recommended